What is known about the epidemiology of the vascultides?

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 191-207

  Watts, Richard A ^a   Lane, Suzanne ^b   Scott, David G I ^a,c  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Malignancy; Vasculitis

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; CARBIMAZOLE; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; DIAMORPHINE; HEPATITIS A VACCINE; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHAMPHETAMINE; MINOCYCLINE; MONTELUKAST; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PHENYLPROPANOLAMINE; PHENYTOIN; PRANLUKAST; PROPYLTHIOURACIL; SALAZOSULFAPYRIDINE; SILICON DIOXIDE; STEROID; TETRACYCLINE; THIAMAZOLE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VANCOMYCIN; ZAFIRLUKAST;

AGE DISTRIBUTION; ALLERGIC VASCULITIS; ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; BIOPSY TECHNIQUE; BLADDER CANCER; CLINICAL FEATURE; CRYOGLOBULINEMIA; DEMOGRAPHY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EUROPE; FUME; GIANT CELL ARTERITIS; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; INCIDENCE; INFECTION; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYELODYSPLASIA; NECROTIZING ARTERITIS; PARTICULATE MATTER; PLASMAPHERESIS; POLYARTERITIS NODOSA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SYSTEMIC VASCULITIS; VASCULITIS; WEGENER GRANULOMATOSIS; AGE; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; HUMANS; RISK FACTORS; SEX FACTORS; VASCULITIS;

EID: 17644411042     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.11.006     Document Type: Review

References (75)

1. E.L. Matteson Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Kawasaki, Takayasu, Behçet and Kawasaki Arthritis Care Res 13 2000 237-245
2. J.F. Fries G.G. Hunder D.A. Bloch The American College of Rheumatology 1990 criteria for the classification vasculitis: Summary Arthritis Rheum 33 1990 1135-1136
3. J.C. Jennette R.J. Falk K. Andrassy Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 1994 187-192
4. R.A. Watts W. Koldingsnes H. Nossent Epidemiology of vasculitis in Europe Ann Rheum Dis 60 2001 1156-1157
5. M. Gonzalez-Gay C. Garcia-Porrua J. Guerrero The epidemiology of the primary systemic vasculitides in Northwest Spain: Implication of the Chapel Hill Consensus Conference Definitions Arthritis Rheum (Arthritis Care Res) 49 2003 388-393
6. A. Mohammad L. Jacobsson M. Segelmark G. Sturfelt Prevalence of small vessel vasculitis in Southern Sweden-preliminary report Kidney Blood Press Res 26 2003 249-302
7. A. Mahr L. Guillevin M. Poissonnet S. Ayme Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis and Churg Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate Arthritis Rheum (Arthritis Care Res) 51 2004 92-99
8. W. Koldingsnes J.C. Nossent Epidemiology of Wegener's granulomatosis in northern Norway Arthritis Rheum 43 2000 2481-2487
9. www.rheuma.uni-luebeck.de/vask-reg.html. Accessed 7 July 2004.
10. J.M. Gardner-Medwin P. Dolezalova C. Cummins T.R. Southwood Incidence of Henoch Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins Lancet 360 2002 1197-1202
11. M.R. Sivakumar A. Chandrakantan The pattern of ANCA-associated vasculitis in India Rheumatology 40 supplment 1 2001 124
12. K. El-Reshaid M. Kapoor W. El-Reshaid The spectrum of renal disease associated with microscopic polyangiitis and polyarteritis nodosa in Kuwait Nephrol Dial Transplant 12 1997 1874-1882
13. B.J. McMahon W.L. Heyward D.W. Templin Hepatitis B associated polyarteritis nodosa in Alaskan Eskimos: Clinical and epidemiological features and long term follow up Hepatology 9 1989 97-101
14. C. Nordberg H. Johanssen V. Petursdottir E. Nordberg The epidemiology of giant cell arteritis: Special reference to changes in the age of the population Rheumatology 42 2003 549-552
15. R.A. Watts D.G.I. Scott Epidemiology of vasculitis In G.V. Ball S.L. Bridges (Eds.), Vasculitis 2002 Oxford University Press Oxford 211-226
16. C. Salvarani C.S. Crowson W.M. O'Fallon Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a 50 year period Arthritis Rheum (Arthritis Care Res) 51 2004 264-268
17. M. Gonzalez-Gay C. Garcia-Porrua J.C. Amor-Dorado J. Llorca Influence of age, sex, and place of residence on the clinical expression of giant cell arteritis in North West Spain J Rheumatol 30 2003 1548-1551
18. N.H. Liu L.D. LaBree S.E. Feldon N.A. Rao The epidemiology of giant cell arteritis: A 12 year retrospective study Ophthalmology 108 2001 1145-1149
19. S. Kobayashi T. Yano Y. Matsumoto Clinical and epidemiological analysis of giant cell arteritis from a nationwide survey in 1998 in Japan: The first government supported nationwide survey Arthritis Rheum (Arthritis Care Res) 49 2003 594-598
20. S. Hall W. Barr J.T. Lie Takayasu arteritis a study of 32 North American patients Medicine 64 1985 89-99
21. A.U. Waern P. Andersson A. Hemmingsson Takayasu arteritis: A hospital based study on the occurrence, treatment and prognosis Angiology 34 1983 311-320
22. K. El-Reshaid J. Varro Q. Al-Duwairi Takayasu arteritis in Kuwait J Trop Med Hyg 98 1995 299-305
23. K. Koide Takayasu arteritis in Japan Heart Vessels 7 1992 48-52
24. H. Yanagawa Y. Nakamura M. Yashiro Incidence survey of Kawasaki disease in 1997 and 1998 in Japan Pediatrics 107 2001 E33
25. R.A. Watts D. Scott Epidemiology of the vasculitides Semin Respir Crit Care Med 2005 [in press]
26. R.A. Watts V.A. Jolliffe C.E.H. Grattan Cutaneous vasculitis in a defined population-clinical and epidemiological associations J Rheumatol 25 1998 420-424
27. C. Garcia-Porrua M.A. Gonzalez-Gay Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch Schonlein purpura in adults Semin Arthritis Rheum 28 1999 404-412
28. T. Somer S. Finegold Vasculitides associated with infections, immunization and antimicrobial drugs Clin Infect Dis 20 1995 1010-1036
29. P. Elling A.T. Olsson H. Wiling Synchronous variations in the incidence of temporal arteritis and polymyalgia rheumatica in different regions in Denmark, association with epidemics of Mycoplasma pneumoniae infection J Rheumatol 23 1996 112-119
30. M.G. Rosso J. Waxman A. Abdoh L.H. Serebro Correlation between infection and the onset of the giant cell arteritis syndrome Arthritis Rheum 38 1995 374-380
31. M. Tidman R. Olander C. Svalander Patients hospitalized because of small vessel vasculitis with renal involvement in the period 1975-95: Organ involvement, anti-neutrophil cytoplasmic antibody patterns, seasonal attack rates and fluctuation of annual frequencies J Intern Med 244 1998 133-141
32. L. Guillevin Virus associated vasculitides Rheumatology 38 1999 588-590
33. C. Ferri D. Giuggioli M. Cazzato HCV-related cryoglobulinaemic vasculitis: An update on its eitopathogenesis and therapeutic strategies Clin Exp Rheumatol 32 6 supplement 32 2003 S78-S84
34. W. Winn Chatham Miscellaneous forms of vasculitis In G.V. Ball S.L. Bridges (Eds.), Vasculitis 2002 Oxford University Press Oxford 513-532
35. E. Popa C. Stegeman C. Kallenberg J. Cohen Tervaert Staphylococcus aureus and Wegener's granulomatosus Arthritis Res Ther 4 2002 77-79
36. J.W. Tarvaert C.A. Stegeman C.G. Kallenberg Silicon exposure and vasculitis Curr Opin Rheumatol 10 1998 12-17
37. M. Yashiro E. Muso T. Itoh-Ihara Significantly high regional morbidity of MPO-ANCA related angiitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan) Am J Kidney Dis 35 2000 889-895
38. S.L. Hogan K.K. Satterly M.A. Dooley Silica exposure in antineutrophil cytoplasmic antibody-associated glomerulonephritis and lupus nephritis J Am Soc Nephrol 12 2001 134-142
39. G. Gregorini A. Ferrioli F. Donato Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: A hospital-based case-control study Adv Exp Med Biol 336 1993 435-440
40. G.D. Nuyts E. van Vlem A. De Vos Wegener's granulomatosis is associated to exposure to silicon compounds: A case-control study Nephrol Dial Transplant 10 1995 1162-1165
41. S.E. Lane R.A. Watts G. Bentham Are environmental factors important in primary systemic vasculitis? A case-control study Arthritis Rheum 48 2003 814-823
42. P. Stratta A. Messuerotti C. Canavese The role of metals in autoimmune vasculitis: Epidemiological and pathogenic study Sci Total Environ 270 2001 179-190
43. G.F. Duna M.F. Cotch C. Galperin Wegener's granulomatosis: Role of environmental exposures Clin Exp Rheumatol 16 1998 669-674
44. P. Pai J.M. Bone G.M. Bell Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis Nephrol Dial Transplant 13 1998 1321-1323
45. S.M. Holder M.S. Joy R.J. Falk Cutaneous and systemic manifestations of drug-induced vasculitis Ann Pharmacother 36 2002 130-147
46. K.M. Dolman R.O. Gans T.J. Vervaat Vasculitis and antineutrophil cytoplasmic antibodies associated with propylthiouracil therapy Lancet 342 1993 651-652
47. H.K. Choi P.A. Merkel A.M. Walker J.L. Niles Drug induced antineutrophil cytoplasmic antibody positive vasculitis-prevalence among patients with high titres of myeloperoxidase antibodies Arthritis Rheum 43 2000 405-413
48. J. Frankel R. Teuez C. Reyes Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism Rev Med Chile 121 1993 1289-1294
49. S.J. Jarrett G. Cunnane P.G. Conagham Anti-tumour necrosis factor therapy induced vasculitis: Case series J Rheumatol 30 2003 2287-2291
50. W.L. Gross Churg-Strauss syndrome: Update on recent developments Curr Opin Rheumatol 14 2002 11-14
51. M.J. Cuadrado D. D'Cruz M. Lloyd Allergic disorders in systemic vasculitis: A case control study Br J Rheumatol 33 1994 749-753
52. D. Wraith M. Goldman P. Lambert Vaccination and autoimmune disease: What is the evidence? Lancet 362 2003 1659-1666
53. P. Phanupak P. Kohler Onset of polyarteritis nodosa during allergic hyposensitisation treatment Am J Med 68 1980 479-485
54. T. Kawsakai Kawasaki disease In G.V. Ball S.L. Bridges (eds.), Vasculitis 2002 Oxford University Press Oxford 2329-2339
55. M.C. Calvino J. Llorca C. Garcia-Porrua Henoch Schonlein purpura in children from Northwestern Spain Medicine 80 2001 279-290
56. R. Blanco V.M. Martinez-Taboada V. Rodriguez-Valverde Henoch-Schonlein purpura in adulthood and childhood Arthritis Rheum 40 1997 859-864
57. V.M. Belostotsky V. Shah M.J. Dillon Clinical features in 17 paediatric patients with Wegener's granulomatosis Pediatr Nephrol 17 2002 754-761
58. M. Rottem A.S. Fauci C.W. Hallahan Wegener's granulomatosis in children and adolescents: Clinical presentation and outcome J Pediatr 122 1993 26-31
59. M. Vassallo R.J. Shepherd P. Iqbal J. Feehally Age-related variations in presentation and outcome in Wegener's granulomatosis J R Coll Phys 31 1997 396-400
60. S. Lane R. Watts L. Shepstone D. Scott Primary systemic vasculitis (PSV)-mortality in a population based cohort Rheumatology 41 supplement 2001 19
61. G.G. Hunder D.A. Bloch B.A. Michel The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis Arthritis Rheum 33 1990 1122-1128
62. G.W. Smetana R.H. Shmerling Does this patient have temporal arteritis? JAMA 287 2002 92-101
63. M.A. Gonzalez-Gay C. Garcia-Porrua J.C. Amor-Dorado J. Llorca Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain J Rheumatol 30 2003 1548-1551
64. R. Blanco V.M. Martinez-Taboada V. Rodriguez-Valverde M. Garcia-Fuentes Cutaneous vasculitis in children and adults Semin Arthritis Rheum 77 1998 403-418
65. T.E. Hutson G.S. Hoffman Temporal concurrence of vasculitis and cancer: a report of 12 cases Arthritis Care Res 13 2000 417-423
66. E. Tatsis E. Reinhold-Keller K. Steindorf Wegener's granulomatosis associated with renal cell carcinoma Arthritis Rheum 42 1999 751-756
67. A. Knight J. Askling A. Ekbom Cancer incidence in a population based cohort of patients with Wegener's granulomatosis Int J Cancer 100 2002 82-85
68. T. Pankhurst C. Savage C. Gordon L. Harper Malignancy is increased in ANCA-associated vasculitis Rheumatology 2004 10.1093/rheumatology/keh374
69. E. Pertuiset F. Liote E. Launay-Russ Adult Henoch-Schönlein purpura associated with malignancy Semin Arthritis Rheum 29 2000 360-367
70. R. Blanco V.M. Martinez-Taboada V. Rodriguez-Valverde M. Garcia-Fuentes Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients Medicine (Baltimore) 77 1998 403-418
71. M.A. Hamidou S. Derenne M.A. Audrain Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study Rheumatology 39 2000 417-420
72. P. Hasler H. Kistler H. Gerber Vasculitides in hairy cell leukaemia Semin Arthritis Rheum 25 1995 134-142
73. I.B. Bayer-Garner B.R. Smollert Leucocytoclastic vasculitis in multiple myeloma Clin Exp Dermatol 28 2003 521-524
74. R.A. Watts S.E. Lane D.G.I. Scott Ottawa methods group Primary systemic vascultis P. Tugwell Evidence-based rheumatology 2004 BMJ Publishing London 495-528
75. K.W. Westman P.G. Bygren H. Olsson Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement J Am Soc Nephrol 9 1998 842-852